These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 36879529)

  • 1. A review of challenges and prospects of 3D cell-based culture models used for studying drug induced liver injury during early phases of drug development.
    Chipangura JK; Ntamo Y; Mohr B; Chellan N
    Hum Exp Toxicol; 2023; 42():9603271221147884. PubMed ID: 36879529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of novel tools for the in vitro investigation of drug-induced liver injury.
    Jiang J; Wolters JE; van Breda SG; Kleinjans JC; de Kok TM
    Expert Opin Drug Metab Toxicol; 2015; 11(10):1523-37. PubMed ID: 26155718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current limitations and future opportunities for prediction of DILI from in vitro.
    Funk C; Roth A
    Arch Toxicol; 2017 Jan; 91(1):131-142. PubMed ID: 27766365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-dimensional (3D) liver cell models - a tool for bridging the gap between animal studies and clinical trials when screening liver accumulation and toxicity of nanobiomaterials.
    Tutty MA; Movia D; Prina-Mello A
    Drug Deliv Transl Res; 2022 Sep; 12(9):2048-2074. PubMed ID: 35507131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioprinted 3D Primary Liver Tissues Allow Assessment of Organ-Level Response to Clinical Drug Induced Toxicity In Vitro.
    Nguyen DG; Funk J; Robbins JB; Crogan-Grundy C; Presnell SC; Singer T; Roth AB
    PLoS One; 2016; 11(7):e0158674. PubMed ID: 27387377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of three-dimensional cell culture in therapeutics and diagnostics: an updated review.
    Biju TS; Priya VV; Francis AP
    Drug Deliv Transl Res; 2023 Sep; 13(9):2239-2253. PubMed ID: 36971997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3D cell culture models: Drug pharmacokinetics, safety assessment, and regulatory consideration.
    Wang H; Brown PC; Chow ECY; Ewart L; Ferguson SS; Fitzpatrick S; Freedman BS; Guo GL; Hedrich W; Heyward S; Hickman J; Isoherranen N; Li AP; Liu Q; Mumenthaler SM; Polli J; Proctor WR; Ribeiro A; Wang JY; Wange RL; Huang SM
    Clin Transl Sci; 2021 Sep; 14(5):1659-1680. PubMed ID: 33982436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technological advancements for the development of stem cell-based models for hepatotoxicity testing.
    Natale A; Vanmol K; Arslan A; Van Vlierberghe S; Dubruel P; Van Erps J; Thienpont H; Buzgo M; Boeckmans J; De Kock J; Vanhaecke T; Rogiers V; Rodrigues RM
    Arch Toxicol; 2019 Jul; 93(7):1789-1805. PubMed ID: 31037322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in three-dimensional cell culturing to assess liver function and dysfunction: from a drug biotransformation and toxicity perspective.
    Calitz C; Hamman JH; Fey SJ; Wrzesinski K; Gouws C
    Toxicol Mech Methods; 2018 Jun; 28(5):369-385. PubMed ID: 29297242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of metabolism-induced hepatotoxicity on three-dimensional hepatic cell culture and enzyme microarrays.
    Yu KN; Nadanaciva S; Rana P; Lee DW; Ku B; Roth AD; Dordick JS; Will Y; Lee MY
    Arch Toxicol; 2018 Mar; 92(3):1295-1310. PubMed ID: 29167929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards improved hepatocyte cultures: Progress and limitations.
    Ruoß M; Vosough M; Königsrainer A; Nadalin S; Wagner S; Sajadian S; Huber D; Heydari Z; Ehnert S; Hengstler JG; Nussler AK
    Food Chem Toxicol; 2020 Apr; 138():111188. PubMed ID: 32045649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Automated Multiplexed Hepatotoxicity and CYP Induction Assay Using HepaRG Cells in 2D and 3D.
    Ott LM; Ramachandran K; Stehno-Bittel L
    SLAS Discov; 2017 Jun; 22(5):614-625. PubMed ID: 28346810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxicity evaluation using cryopreserved primary human hepatocytes in various culture formats.
    Richert L; Baze A; Parmentier C; Gerets HHJ; Sison-Young R; Dorau M; Lovatt C; Czich A; Goldring C; Park BK; Juhila S; Foster AJ; Williams DP
    Toxicol Lett; 2016 Sep; 258():207-215. PubMed ID: 27363785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-Culture of Human Primary Hepatocytes and Nonparenchymal Liver Cells in the Emulate® Liver-Chip for the Study of Drug-Induced Liver Injury.
    Shi Q; Arefin A; Ren L; Papineau KS; Barnette DA; Schnackenberg LK; Hawes JJ; Avigan M; Mendrick DL; Ewart L; Ronxhi J
    Curr Protoc; 2022 Jul; 2(7):e478. PubMed ID: 35790095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro.
    Novac O; Silva R; Young LM; Lachani K; Hughes D; Kostrzewski T
    J Vis Exp; 2022 Jan; (179):. PubMed ID: 35156664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Vitro Models for Studying Chronic Drug-Induced Liver Injury.
    Donato MT; Gallego-Ferrer G; Tolosa L
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent Progress in Prediction Systems for Drug-induced Liver Injury Using In vitro Cell Culture.
    Ozawa S; Miura T; Terashima J; Habano W; Ishida S
    Drug Metab Lett; 2021; 14(1):25-40. PubMed ID: 33267768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of human drug-induced liver injury (DILI) in relation to oral doses and blood concentrations.
    Albrecht W; Kappenberg F; Brecklinghaus T; Stoeber R; Marchan R; Zhang M; Ebbert K; Kirschner H; Grinberg M; Leist M; Moritz W; Cadenas C; Ghallab A; Reinders J; Vartak N; van Thriel C; Golka K; Tolosa L; Castell JV; Damm G; Seehofer D; Lampen A; Braeuning A; Buhrke T; Behr AC; Oberemm A; Gu X; Kittana N; van de Water B; Kreiling R; Fayyaz S; van Aerts L; Smedsrød B; Ellinger-Ziegelbauer H; Steger-Hartmann T; Gundert-Remy U; Zeigerer A; Ullrich A; Runge D; Lee SML; Schiergens TS; Kuepfer L; Aguayo-Orozco A; Sachinidis A; Edlund K; Gardner I; Rahnenführer J; Hengstler JG
    Arch Toxicol; 2019 Jun; 93(6):1609-1637. PubMed ID: 31250071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3D organotypic HepaRG cultures as in vitro model for acute and repeated dose toxicity studies.
    Mueller D; Krämer L; Hoffmann E; Klein S; Noor F
    Toxicol In Vitro; 2014 Feb; 28(1):104-12. PubMed ID: 23850736
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Mirahmad M; Sabourian R; Mahdavi M; Larijani B; Safavi M
    Drug Metab Rev; 2022 May; 54(2):161-193. PubMed ID: 35403528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.